RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 1995;88:570-575
© 1995 Royal Society of Medicine

This Article
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, K. P.
Right arrow Articles by Usherwood, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of the Royal Society of Medicine, Vol 88, Issue 10 570-575, Copyright © 1995 by Royal Society of Medicine

ORIGINAL ARTICLES

The effects on prescribing patterns and costs of having a special interest in asthma

KP Jones, CM Harris, SM Bogle, R Foley and TP Usherwood
General Practitioners in Asthma Group, Medical Marketing Interface, Bath Brewery, England, UK.

To define the characteristics of general practices with a special clinical interest in asthma and to estimate the resulting extra prescribing costs, we sent a postal questionnaire to all English practices containing members of the General Practitioners in Asthma Group. Item and cost comparisons for 24 PACT (prescribing analysis and cost) aggregates were made between practices who had operated an agreed, written management plan for asthma before 1 April 1990 and all other practices in their respective Family Health Services Authorities. One hundred and sixty-three practices with GPIAG members responded (70%), of which 26 filled the management plan requirement. These 26 practices showed evidence of significantly better asthma care provision than the remainder of the sample. Their prescribing costs were significantly higher for respiratory drugs (median 37% higher) but lower in other drug categories. For respiratory drugs, costs were significantly higher for inhaled adrenoceptor stimulants, steroid inhalers, large spacers, and peak flow meters, but lower for cough medicines and systemic nasal decongestants: the number of items prescribed showed similar patterns. The prescribing costs of practices claiming a special interest in asthma are likely to show higher respiratory drug costs, but overall prescribing costs showed no increase in the practices studied.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
G. van den BOOM, C. P. van SCHAYCK, M. P. M. H. RUTTEN-van MOLKEN, P. R. S. TIRIMANNA, J. J. den OTTER, P. M. van GRUNSVEN, M. J. BUITENDIJK, C. L. A. van HERWAARDEN, and C. van WEEL
Active Detection of Chronic Obstructive Pulmonary Disease and Asthma in the General Population . Results and Economic Consequences of the DIMCA Program
Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1730 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 Health Informatics JournalHome page
P. Sturdy and A.E. Livingstone
Can general practice computer data be of use in assessing asthma service delivery and needs?
Health Informatics Journal, January 1, 1997; 3(2): 93 - 99.
[Abstract] [PDF]


MDU Exam Doctor

 Anatomy Flash Cards International Journal of Care Pathways